MedPath

Eliminating HCV Infection Among PWUD

Recruiting
Conditions
Hepatitis C, Chronic
Drug Use
Registration Number
NCT05474781
Lead Sponsor
Vancouver Infectious Diseases Centre
Brief Summary

Identify 300 PWUD with chronic, viremic HCV infection and engage them in a multidisciplinary, generalizable model of care and initiate HCV treatment

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. Ability to review, sign and date the IRB/IEC approved informed consent form
  2. Age ≥19 years
  3. Documented HCV RNA positive for 6 months or more, with any HCV genotype
  4. Active PWUD (ongoing drug use or documented use within the previous 6 months) OR active enrolment in an opiate substitution program
Exclusion Criteria
  1. Previous DAA-based HCV treatment
  2. Pregnant or breast-feeding
  3. Indications of decompensated liver disease
  4. Diagnosis of active hepatocellular carcinoma
  5. Positive test at the time of screening for hepatitis B surface antigen (HBsAg)
  6. Frequent injecting drug use that is judged by the treating physician to compromise subsequent HCV treatment safety
  7. Inability or unwillingness to provide informed consent or to actively engage in care leading to the initiation of HCV treatment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of individuals enrolled in the study who initiate HCV treatment60 months
Secondary Outcome Measures
NameTimeMethod
The proportion of individuals enrolled in the study who achieve sustained virologic response72 months

Trial Locations

Locations (1)

Vancouver Infectious Diseases Centre

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath